Amgen pays $2.2bn for Abgenix

Amgen, the US biotechnology company, is buying Abgenix for $2.2bn (€1.8bn) in the largest M&A deal in the US biotech sector. Morgan Stanley is advising Amgen and Goldman Sachs is adviser to Abgenix.

Sullivan & Cromwell is legal counsel to Amgen and Dewey Ballantine is legal adviser for Abgenix.

WSJ Logo
Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With TrumpExternal link

Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With Trump